The Blue Zone Consortium

到2040年，英国近七分之一的人预计将超过75岁，许多人患有多种疾病。相比之下，蓝区是世界上慢性病发病率较低的地区，那里的人们生活得更健康。该联盟将支持研究人员超越传统的学科界限，跨部门合作，制定和实施可行的解决方案，将前沿生物科学带到蓝区成果。我们新成立的蓝区联盟FTMA的目的是促进跨部门合作，增加CO-通过人员的转移，创造研究和明确的想法和技术。我们的目标是提高研究人员和技术专业人员的技能通过接触新的思维方式和环境，从职业生涯的早期阶段开始，我们将：通过比赛来传播资金，以支持交流和动员提供多层次的创业和跨学科技能培训计划创建网络活动，促进合作和知识交流平等，多样性和包容性是这个联盟的核心：从早期的职业学者推动由合作机构教授支持的这一建议的开始，到我们对ECR和技术专业培训的关注，机会和各级代表。我们的电子数据交换政策确保代表性不足的群体享有平等的机会，并使我们的联盟更聪明、更创新和更有社会意识。我们的管理委员会由Richard Emes教授担任主席，负责监督政策和程序的制定、批准资源分配和监督进度。执行团队将确保FTMA的运营交付，与成员沟通，处理资金申请，并确保遵守我们的EDI政策。为了确保我们的决策过程的稳健性，资金申请将由来自适当部门的=2名独立专家进行评估，然后在授予之前进行小组审查。我们的提案符合UKRI的优先领域：确保更好的健康，老龄化和福祉。我们将支持与该联盟的三个横向主题相关的生物科学研究：代谢健康;整个生命过程中的健康和老龄化;以及解决健康不平等的变革性技术。诺丁汉特伦特大学，莱斯特大学，和诺森比亚大学各自带来了丰富的交叉网络-部门合作者，将协同工作，以创造跨学科的项目。莱斯特大学带来了多学科和国际转化科学的专业知识，支持该联盟的全球目标，包括与区域NHS信托基金的重要联系，以及包括BHF心血管研究中心，糖尿病研究中心，民族健康研究中心和NIHR东米德兰应用研究合作的研究中心。这些网络将支持代谢健康的联盟研究，并补充诺丁汉特伦特大学系统健康和综合代谢研究中心和医疗技术创新设施的优势，这是一个开创性的双站点研究和开发设施，为学术界和工业界提供桥梁，以加速创新医疗技术。诺森比亚大学，谁专注于健康老龄化从各种细胞，激素，肌肉，实践和干预方面有支持毕业生在企业的跟踪记录，以他们与ART健康解决方案的工作为例，现在已经吸引了近100万英镑的投资从KTP和风险基金.整个联盟的免费研究的临界质量，并达到500多家公司，六个NHS信托基金和更广泛的护理环境使我们成为支持研究人员从基础生物科学研究跨越峡谷到最终用户利益的理想场所。

By 2040, nearly one in seven people in the UK is projected to be aged over 75, many living with multiple morbidities. By contrast, Blue Zones are areas across the world with lower rates of chronic disease, where people live longer healthier lives. This consortium will support researchers to transcend traditional disciplinary boundaries and collaborate across sectors to formulate and implement viable solutions that take frontier bioscience to blue zone outcomes.The aim of our new Blue Zone Consortium FTMA is to promote cross-sectoral collaboration, increase co-creation of research and clarity of ideas and technologies through the transfer of people.Our objectives will upskill researchers and technical professionals right from early career stages by exposure to new ways of thinking and environments, we will:disseminate funding via competitions to support exchange and mobilisationdeliver multi-level entrepreneurial and transdisciplinary skills training programmescreate networking events that promote collaboration and knowledge exchangeEquality, diversity and inclusion are at the heart of this consortium: from early career academics driving inception of this proposal supported by a partner institution professoriate to our focus on ECR and technical professional training, opportunities, and representation at all levels. Our EDI policy ensures equity of opportunity for underrepresented groups, and makes our consortium smarter, more innovative and more socially aware.Our governance board, chaired by Professor Richard Emes, will oversee the development of policies and processes, approve resource allocation and monitor progress. The executive team will ensure operational delivery of the FTMA, communicating with members, handling funding applications, and ensuring compliance with our EDI policy. To safeguard the robustness of our decision making process, funding applications will be assessed by =2 independent experts from appropriate sectors, followed by panel review prior to award.Our proposal aligns with the UKRI priority area: securing better health, ageing, and wellbeing. We will support bioscience research related to the three transversal themes of this consortium: metabolic health; health and ageing across the life course; and transformative technologies to tackle health inequalities.Partner universities: Nottingham Trent University, University of Leicester, and Northumbria University each bring a rich network of cross-sector collaborators that will work synergistically to create transdisciplinary projects.The University of Leicester brings expertise in multidisciplinary and international translational science that support consortium global ambitions, including significant links with regional NHS Trusts, and research centres including the BHF Cardiovascular Research Centre, Diabetes Research Centre, Centre for Ethnic Health Research, and NIHR East Midlands Applied Research Collaboration. These networks will support consortium research in metabolic health and compliment strengths at Nottingham Trent University's Centre for Systems Health and Integrated Metabolic Research and Medical Technologies Innovation Facility, a pioneering dual-site research and development facility, that provides a bridge between academia and industry, to enable the acceleration of innovative medical technologies. Northumbria University, who focus on healthy ageing from a variety of cellular, hormonal, muscular, practical and interventional aspects have a track record of supporting graduates in enterprise, exemplified by their work with ART Health Solutions, which has now attracted almost £1M investment from KTP and venture funds.The critical mass of complimentary research across our consortium and reach to over 500 companies, six NHS Trusts and wider care settings makes us ideally placed to support researchers on their journey to jump the canyon from fundamental bioscience research into end user benefit.